4//SEC Filing
BELANOFF JOSEPH K 4
Accession 0000950170-25-081939
CIK 0001088856other
Filed
Jun 3, 8:00 PM ET
Accepted
Jun 4, 8:41 PM ET
Size
19.5 KB
Accession
0000950170-25-081939
Insider Transaction Report
Form 4
BELANOFF JOSEPH K
DirectorChief Executive Officer10% Owner
Transactions
- Sale
Common Stock
2025-06-02$80.30/sh−2,988$239,941→ 2,931,066 total(indirect: By Trust) - Sale
Common Stock
2025-06-02$79.48/sh−3,050$242,421→ 2,934,054 total(indirect: By Trust) - Sale
Common Stock
2025-06-02$84.57/sh−12,959$1,095,962→ 2,910,393 total(indirect: By Trust) - Sale
Common Stock
2025-06-02$78.42/sh−4,881$382,773→ 2,937,104 total(indirect: By Trust) - Sale
Common Stock
2025-06-02$85.01/sh−8,408$714,778→ 2,901,985 total(indirect: By Trust) - Sale
Common Stock
2025-06-02$82.26/sh−1,263$103,899→ 2,927,983 total(indirect: By Trust) - Sale
Common Stock
2025-06-02$83.46/sh−4,631$386,523→ 2,923,352 total(indirect: By Trust) - Sale
Common Stock
2025-06-02$81.33/sh−1,820$148,012→ 2,929,246 total(indirect: By Trust)
Footnotes (10)
- [F1]This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2024 in effect at the time of this transaction.
- [F10]Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $85.00 to $85.31 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
- [F2]Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $77.84 to $78.83 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
- [F3]Reporting Person has voting power over the shares held by the Joseph K. Belanoff and Katherine A. Blenko Revocable Living Trust DTD 04/29/02 pursuant to voting agreements and disclaims beneficial ownership of all of such shares, except to the extent of his pecuniary interest therein.
- [F4]Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $78.88 to $79.865 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
- [F5]Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $79.90 to $80.8925 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
- [F6]Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $80.92 to $81.78 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
- [F7]Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $81.935 to $82.80 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
- [F8]Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $82.96 to $83.95 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
- [F9]Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $83.975 to $84.94 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
Documents
Issuer
CORCEPT THERAPEUTICS INC
CIK 0001088856
Entity typeother
Related Parties
1- filerCIK 0001286199
Filing Metadata
- Form type
- 4
- Filed
- Jun 3, 8:00 PM ET
- Accepted
- Jun 4, 8:41 PM ET
- Size
- 19.5 KB